CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Elpen Pharmaceutical against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 14, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 21, 2025
New UseNOVARTISJul 11, 2024
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISOct 20, 2022

Top competitors of Elpen Pharmaceutical

Top competitors of Elpen Pharmaceutical based on patent oppositions.